Compare MRK & TTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MRK | TTE |
|---|---|---|
| Founded | 2000 | 1924 |
| Country | United States | France |
| Employees | N/A | 101513 |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 268.7B | 205.5B |
| IPO Year | 1994 | N/A |
| Metric | MRK | TTE |
|---|---|---|
| Price | $114.78 | $82.21 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 17 | 8 |
| Target Price | ★ $125.59 | $76.63 |
| AVG Volume (30 Days) | ★ 8.4M | 1.2M |
| Earning Date | 04-30-2026 | 04-29-2026 |
| Dividend Yield | 3.06% | ★ 4.14% |
| EPS Growth | ★ 8.01 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $65,011,000,000.00 | N/A |
| Revenue This Year | $3.61 | $28.83 |
| Revenue Next Year | $5.41 | N/A |
| P/E Ratio | ★ N/A | $12.60 |
| Revenue Growth | ★ 1.31 | N/A |
| 52 Week Low | $76.66 | $57.40 |
| 52 Week High | $125.14 | $94.17 |
| Indicator | MRK | TTE |
|---|---|---|
| Relative Strength Index (RSI) | 46.23 | 27.44 |
| Support Level | $112.96 | $76.56 |
| Resistance Level | $123.93 | $82.21 |
| Average True Range (ATR) | 2.93 | 1.51 |
| MACD | -0.47 | -0.69 |
| Stochastic Oscillator | 18.60 | 1.10 |
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
TotalEnergies is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2025, it produced 1.5 million barrels of liquids and 5.4 billion cubic feet of natural gas per day. At the end of 2025, reserves stood at 11.2 billion barrels of oil equivalent, 55% of which are liquids. During 2025, it had LNG sales of 43.9 million metric tons. The company owns interests in refineries with a capacity of nearly 1.8 million barrels a day, primarily in Europe, distributes refined products in 65 countries, and manufactures commodity and specialty chemicals. At year-end, its gross installed renewable power generation capacity was 34 gigawatts.